eIntroduction
After recovering strongly along with the broader market after the COVID-19 crash, Bayer (OTCPK:BAYRY, OTCPK:BAYZF) shares are now back in no man's land.
This underperformance may almost come as a surprise, as there have recently been several possible upside catalysts. In addition to the general stock market rally, the current quarterly figures have shown that the company came through the COVID-19 crisis quite successfully. There were also some rays of hope regarding the many litigation risks. I will also show you that from a fundamental perspective, Bayer is